Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
~ great work on board much appreciated ~ long $VXIT ~
~ can followthecharts here ~ https://stocktwits.com/followthecharts
~ great work on board much appreciated ~ long $UATG ~
~ can followthecharts here ~ https://stocktwits.com/followthecharts
$QBAN ~ setting up real nice on the 2hr ~ big poppy by eow ~
stockcharts.com/h-sc/ui?s=QBAN&p=120&b=5&g=0&id=p67375175572&a=916514379&listNum=2
$QBAN ~ setting up real nice on the 2hr ~ big poppy by eow ~
insert-text-here
$BPMX in @.88
$SRRA added more .67's looks to be just starting out here imo
$SRRA in @.677
like the momo
charts looks great
.40 this week imo
$HSGX
Agreed...
yes, massive volume
gonna get fun
$HSGX
gonna get fun here .28 break and .32 should send it
$HSGX
Agreed...
$TIGR in @ 4.80
$TXMD Press Release
TherapeuticsMD and Theramex Enter into Exclusive License and Supply Agreement to Commercialize BIJUVA™ and IMVEXXY® Outside the United States
Published: June 7, 2019 7:15 a.m. ET
https://www.marketwatch.com/press-release/therapeuticsmd-and-theramex-enter-into-exclusive-license-and-supply-agreement-to-commercialize-bijuvatm-and-imvexxy-outside-the-united-states-2019-06-07?mod=mw_quote_news
yes...
like the set up
$TXMD @ 3.22
$INSY moving
$INSY moving
yes
made my day yesterday
Nice
gltus
np i'm in @.24 lookin for .50
$HK moving
$HK moving
$HK in @.24
$HK
$HK
great day here...
go $LGCY
sold 2nd half @.59 ,,,;)
yep! very nice day here
$LGCY Beast! in this morn @.21 out half @.31 riding the other half
EDXC 6m daily chart
insert-text-here
yeah, seems .35 +- has been the load zone for next run up, break @.41 and hold should give us a lil more momo imo
EDXC charts setting up real nice here, bottom appears to be in @.32 expecting to see .75 to 1.00 on the next run up imo
Press Release
CBD Unlimited, Inc. to Present at the 9th Annual LD Micro Invitational in Bel Air, CA
Published: May 30, 2019 12:43 a.m. ET
CAVE CREEK, AZ, May 30, 2019 (GLOBE NEWSWIRE via COMTEX) -- CAVE CREEK, AZ, May 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - CBD Unlimited, Inc. (EDXC) formerly known as Endexx Corporation, a provider of innovative phytonutrient-based food and nutritional products, is pleased to announce that the Company is presenting at the 9th Annual LD Micro Invitational to be held in Bel Air, California on June 4-5, 2019 at the Luxe Sunset Boulevard Hotel.
Mr. Todd Davis, CBD Unlimited's CEO and Chairman, is scheduled to present on, June 4, 2019 at 10:40 AM/ PM PT in track 2. Mr. Davis will be hosting one-on-one meetings throughout the day and is available to meet with investors during the conference. Mr. Davis will present a company overview and provide details on the company's expansion.
To schedule a one-on-one meeting with CBD Unlimited's management, please contact your LD Micro representative or CBD Unlimited's investor relations team.
https://www.marketwatch.com/press-release/cbd-unlimited-inc-to-present-at-the-9th-annual-ld-micro-invitational-in-bel-air-ca-2019-05-30-01844337?mod=mw_quote_news
yes, very nice
added 10k @.46
$EDXC
same here
CBD Unlimited Announces Record-Breaking Quarter for Fiscal Q2
GLOBENEWSWIRE 8:30 AM ET 5/14/2019
Company Reaches Revenues Up 263% Year-Over-Year
CAVE CREEK, AZ, May 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CBD Unlimited, Inc. (EDXC) formerly known as Endexx Corporation(EDXC), a provider of innovative phytonutrient-based food and nutritional products, is pleased to report record revenue growth for its second quarter of fiscal 2019. For the three months ended March 31, 2019, the Company generated over $680,000 in sales, which represents an increase of 263% year-over-year and 184% increase quarter-over-quarter.
Second Quarter 2019 Milestones and Highlights:
CBD Unlimited completed the production of 7.5 million, and counting, wholesale product units of products to meet high demand requirements.
Introduced its Premium Blue Line that represents the company’s controlled-dosing, targeted-delivery and dual-therapy product suite.
Completed its FDA label review for entrance into the pharmacy, food, and mass retail sectors.
CBD Unlimited purchased its corporate headquarters to provide additional space for operations, sales, and additional warehousing.
Engaged CBD Health Solutions, a private sales group, to expand CBD Unlimited’s product reach, both nationally and internationally.
Partnered with Gold Coast Distributors to service over 1,200 plus bodegas and boutiques in the NYC Burroughs 5 with CBD Unlimited’s product line.
“Our second quarter of fiscal 2019 continues to set the pace for the entire year. We generated another record-setting quarter, where we saw an exponential increase year-over-year increase in revenues. As we continue to expand our full-scale production capabilities, we are confident that we will be able to meet our exponentially growing consumer demand,” commented CEO & Chairman Todd Davis. “With the recent passage of the Farm Bill last December, we continue to see an increase in our national and international product reach. Additionally, the FDA called a public hearing regarding CBD that we will be monitoring closely to provide our customers and stakeholders real-time updates. And with the recent launch of our newest Premium Blue label, we are always innovating and enhancing our product line. We look forward to execute continued growth for the rest of 2019.”
About CBD Unlimited, Inc.
CBD Unlimited, Inc., with its collaborative partners and consultants, develops and distributes two consumable product lines derived from Hemp, which is all-natural and rich in phyto-cannabinoids. Phyto-Bites® is its CBD-infused soft chews for dogs. The dog treats are formulated to promote health and support the reduction of separation anxiety, pain and inflammation.
The company also has two key technology products and services that launched in 2014. Both products provide essential solutions to promote regulatory compliance and full accountability through asset protection, inventory management, compliance and an “end of sale” technology integration. Based on principles developed by the pharmacological industry, the integrated “Gorilla-Tek” platform is the first standardized hardware agnostic and software solution for tracking high- risk high-shrink regulated and restricted products that maintains compliance with federal, state and local regulations. It is intended to provide conformity with federal and state mandates. Gorilla-Tek™ is also a commercial-grade inventory control and dispensing device that provides up-to-the-minute accounting details and ensures both product and patient security. By automating the dispensing process, Gorilla-Tek™ increases productivity and reduces costs for retailers, while enhancing their service quality by reducing transaction time for customers.
Websites include: www.cbdunlimited.com, and www.phytobites.com.
Safe Harbor Notice
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.
Contact:
For further investor and media information, contact:
CBD Unlimited, Inc.
Todd Davis
Chairman & CEO
Todd@cbdunlimited.com
480-595-6900
Image: CBD Logo.png
Source: CBD Unlimited, Inc.